H uman essential hypertension is a complex, multifactorial, quantitative trait under polygenic control, with inherited factors contributing ≤ 30% of the variation in blood pressure (BP). 1 The search for the specifi c genetic variations contributing to this heritability remains challenging. Recent genome-wide association studies collectively explain only a very small proportion of the total variation in systolic BP (SBP) or diastolic BP (DBP; ≈ 2.2%), 2 , 3 which suggests the existence of many more undiscovered BP-related variants.
H uman essential hypertension is a complex, multifactorial, quantitative trait under polygenic control, with inherited factors contributing ≤ 30% of the variation in blood pressure (BP). 1 The search for the specifi c genetic variations contributing to this heritability remains challenging. Recent genome-wide association studies collectively explain only a very small proportion of the total variation in systolic BP (SBP) or diastolic BP (DBP; ≈ 2.2%), 2 , 3 which suggests the existence of many more undiscovered BP-related variants.
Genetic detection of complex polygenic diseases is complicated by potential gene -gene, gene -environment interactions, and nonsequence epigenetic modifi cations. In particular, there is growing evidence for epistasis among BP quantitative trait loci (QTL) in inbred rat models of hypertension. 4 -11 We have previously identifi ed BP QTL on rat chromosomes (RNO) 2 and RNO3 in a linkage analysis of an F2 cross between stroke-prone spontaneously hypertensive (SHRSP) and Wistar Kyoto (WKY) rats. 12 We subsequently confi rmed the RNO2 loci with the production of congenic strains and identifi ed candidate genes for baseline BP and response to salt loading. 13 -15 The aims of this study were to confi rm the RNO3 QTL and to investigate interaction between the loci on RNO2 and RNO3 through the generation and phenotypic assessment of single and bicongenic strains.
Methods

Animal Strains
Inbred colonies of SHRSP and WKY have been developed and maintained at the University of Glasgow since 1991, as described previously. 12 All animals were housed under controlled environmental conditions, fed standard rat chow (rat and mouse no No. 1 maintenance diet, Special Diet Services) and water provided ad libitum. At 18 weeks of age, rats were given a salt challenge (1% NaCl in drinking water) for 3 weeks. All animal procedures performed were approved by the Home Offi ce according to regulations regarding experiments with animals in the United Kingdom.
The single RNO3 congenic strain, SP.WKY Gla 3a ( D3Mgh16-D3Rat114 ), was generated using a previously described marker-assisted speed congenic strategy where WKY (donor strain) segments were introgressed into the SHRSP (recipient strain) genetic background. 16 The SP.WKY Gla 2a congenic strain ( D2Rat13-D2Rat157 ) is a previously published strain. 15 , 16 The SP.WKY Gla 2a/3a bicongenic strain, ( D2Rat13-D2Rat157 / D3Mgh16-D3Wox28 ) was generated as follows: F1 rats, bred by crossing SP.WKY Gla 3a and SP.WKY Gla 2a congenic rats, were backcrossed with SP.WKY Gla 2a rats. Progeny heterozygous for RNO3 and homozygous for RNO2 congenic segments were crossed. Progeny homozygous for both congenic intervals were bred to establish the bicongenic strain. A full list of microsatellite markers used for genotyping is shown in Table S1 in the online-only Data Supplement. The nomenclature of the strains consists of the fi rst abbreviation belonging to the recipient strain and the second to the donor: Gla denotes that strains originate from the Glasgow colonies, and the number 2 or 3 refers to the particular rat chromosome. All the studies were conducted in male rats only.
Hemodynamic and Phenotypic Measurements
The Dataquest IV telemetry system (Data Sciences International) was used for the direct measurement of SBP, DBP, and pulse pressure (PP). 12 , 16 Male rats were implanted at 12 weeks of age with 1-week recovery, 5 weeks of baseline measurements, followed by 3 weeks of 1% NaCl in the drinking water. Twenty-four -hour urine samples were collected from all animals using metabolic cages before sacrifi ce. At sacrifi ce, weights for cardiac mass index (CMI), left ventricular mass index (LVMI), and renal mass index (RMI) were measured, thoracic aorta were excised for ex vivo vascular function, and harvested tissues were snap frozen in liquid nitrogen and stored at -80 ° C or fi xed in 4% buffered formaldehyde and paraffi n embedded. CMI, LVMI, RMI, renal histology, and urinary biochemistry were also assessed in age-matched control animals, not receiving salt in their drinking water.
Vascular Function
Thoracic aortas from salt-loaded 21-week-old rats were cleaned of connective tissue and suspended in organ baths, as previously described for measurement of NO bioavailability. 17 Krebs ' buffer in which aortas were maintained, contained indomethacin (0.02 mmol/L) to inhibit any prostanoid-mediated effects. Isometric tension studies were performed using a force transducer and recorded using MacLab. Contractile responses to 10 mmol/L KCl were examined, the baths washed out, and tissues allowed to relax. Cumulative concentration-response curves to phenylephrine (10 nmol/L -100 μ mol/L) were constructed, fi rst in the absence and again after washout, in the presence of 100 μ mol/L NG-nitro-L -arginine methyl ester (L-NAME) to inhibit NO synthase. The increase in tension in the presence of L-NAME provides a measure of the effect of NO on basal tone, and was calculated for each ring over the full doseresponse curve and expressed as area under the curve. In addition, the rings were preconstricted to the EC50 of phenylephrine, and a concentration-response curve for carbachol (10 nmol/L -100 μ mol/L) was obtained which provides a measure of stimulated NO release. Responses to phenylephrine were standardized against the initial contractile response to KCl.
Renal Histology
For renal histology, adjacent transverse sections of kidney (3-μ m thick) were stained with hematoxylin and eosin, elastin muscle fi brin stain, or periodic acid schiff and scored for renal changes according to a previously described scoring system. 18 Images shown were taken with Olympus DP72 attached to Olympus BX51 microscope, using DP2-BSW software.
Urinary Biochemistry Analysis
Urinary protein was measured using Thermo Pierce Protein Assay 660 (no. 22662, Thermo Fisher Scientifi c Inc) according to manufacturer ' s instructions. Urine samples were diluted 1 in 5 for assay.
Statistical Analysis
All results are shown as mean ± SEM, unless otherwise stated. Previously generated data from an F2 cross between SHRSP and WKY 12 were analyzed using Pseudomarker statistical software. 19 , 20 Interaction analysis between QTL on RNO2 and RNO3 was performed using a Pseudomarker 2-dimensional pairscan with a 2-QTL model. This is a simultaneous search for pairs of interacting loci, which tests all pairs of genomic locations for associations with the trait. The 2-dimensional scan calculated logarithm of odds ratio (LOD) scores for the full model (LODfull; 2-QTL model Hemodynamic parameters for WKY or congenic strains were compared with SHRSP, using repeated measures ANOVA, general linear model. The night -day PP difference was calculated as night PP (mm Hg) -day PP (mm Hg). Interactions between RNO2 and RNO3 congenic intervals were investigated using 1-way ANOVA with contrasts (SHRSP versus SP.WKY Gla 2a; SHRSP versus SP.WKY Gla 3a) and the interaction (SHRSP and SP.WKY Gla 2a/3a versus SP.WKY Gla 2a and SP.WKY Gla 3a). The phenotypic measurements were analyzed using 1-way ANOVA with Tukey comparison for 95% confi dence interval. The histology scores for each group were compared using the Kruskal -Wallis test, adjusted for ties. Bonferroni-corrected Mann -Whitney tests were then used for testing signifi cance between group pairs.
Results
Interaction Between RNO2 and RNO3 QTLs
Analysis of the F2 PP data using Pseudomarker statistical software identifi ed an interaction between the lower BP QTL region on RNO2 (peak near marker D2Rat239 ) 16 and the QTL on RNO3 (peak near marker D3Rat50 ; Figure 1B ). The full LOD score (LODfull; 2 QTL model plus interaction)=7.66 and the interaction LOD score (LODint)=4.17; P =0.0007.
It should be noted that the lower RNO3 boundaries between the single RNO3 and the bicongenic strain differ by approximately by 1.9 Mbp. This region is distinct (a distance of ≈ 132.8 Mbp) from the RNO3 QTL peak.
Hemodynamic Parameters of Congenic Strains
SP.WKY Gla 2a and SP.WKY Gla 3a rats demonstrated signifi cantly reduced SBP and DBP at baseline (normal salt) and during 1% salt challenge ( Figure 2A and 2B , Table S2 ). The SP.WKY Gla 3a strain confi rmed the presence of the PP QTL previously identifi ed by linkage analysis ( Figure 2C ) , as evidenced by its signifi cantly lower PP compared with SHRSP rats. PP in SP.WKY Gla 2a rats was also signifi cantly lower than in SHRSP. The SP.WKY Gla 2a/3a bicongenic strain demonstrated a greater reduction in SBP and DBP than either of the single congenic strains, with BP levels similar to that of the normotensive WKY strain both at baseline and during salt challenge ( Figure 2A and 2B ) . SP.WKY Gla 3a and SP.WKY Gla 2a/3a animals also demonstrated signifi cantly reduced night -day PP difference during baseline and salt challenge compared with SHRSP ( Figure 2C -2E ). Night -day PP difference in SP.WKY Gla 2a animals during baseline was Analysis of data using 1-way ANOVA with contrasts between SHRSP versus SP.WKY Gla 2a, SHRSP versus SP.WKY Gla 3a, and the interaction (SHRSP and SP.WKY Gla 2a/3a versus SP.WKY Gla 2a and SP.WKY Gla 3a) indicates that reduced SBP and DBP at baseline ( Figure 3A and 3C ) and during salt challenge ( Figure 3B and 3D ) observed in SP.WKY Gla 2a/3a rats were because of additive effects from RNO2 and RNO3. Statistically signifi cant epistasis between RNO2 and RNO3 was observed for PP during baseline ( Figure 3E ) and salt challenge ( Figure 3F ).
Vascular Function
NO bioavailability in SHRSP and single congenic strains SP.WKY Gla 2a and SP.WKY Gla 3a were signifi cantly lower than WKY rats ( Figure 4A ). NO bioavailability in the SP.WKY Gla 2a/3a strain was not signifi cantly different compared with either SHRSP or WKY or between the single congenic strains and SHRSP. Relaxation responses to carbachol in SHRSP, SP.WKY Gla 2a, SP.WKY Gla 3a, and SP.WKY Gla 2a/3a strains were signifi cantly less than WKY ( Figure 4B ). Relaxation response to carbachol in the SP.WKY Gla 2a strain was signifi cantly improved compared with SHRSP.
Cardiac, Left Ventricular, and Renal Mass Indexes
CMI, LVMI, and RMI of 21-week-old salt-loaded rats are shown in Figure S1B , S1D, and S1F whereas the respective indices of control rats are shown in Figure S1A , S1C, and S1E. Control and salt-loaded SHRSP demonstrated signifi cantly greater CMI, LVMI, and RMI compared with their respective treatment WKY rats. In parallel with observed BP reductions, the single and bicongenic strains demonstrated intermediate CMI and LVMI phenotypes compared with SHRSP and WKY parental strains. RMI was not signifi cantly different between SHRSP and SP.WKY Gla 2a strains, but was 
Renal Histopathology and Proteinuria
Extensive histopathologic changes, including vascular changes consistent with accelerated hypertension, were observed in kidneys from SHRSP and SP.WKY Gla 2a strains ( Figure 5A ). A range of mainly vascular changes was evident in these 2 strains, including hyperplasia, smooth muscle cell vaccuolation, hyalinosis, fi brinoid necrosis, hemorrhage, and thrombosis of both arteries and arterioles. Tubular atrophy and interstital fi brosis were commonly seen in conjunction with these vascular changes. Glomerular changes were rare and usually consisted of mild ischemic collapse of the glomerular tuft in the presence of the abovementioned vascular changes.
Renal pathology scores for single and bicongenic strains at baseline ( Figure 5B ) and during salt challenge ( Figure 5C ) were lower than SHRSP but only reached statistical significance in SP.WKY Gla 3a and SP.WKY Gla 2a/3a rats. The scores of congenic strains were signifi cantly higher than WKY when salt challenged. SP.WKY Gla 2a rats also had signifi cantly higher scores compared with SP.WKY Gla 3a and SP.WKY Gla 2a/3a rats.
At baseline, there was no signifi cant difference in proteinuria between the parental and congenic strains. During salt challenge, SHRSP and SP.WKY Gla 2a rats demonstrated higher levels of proteinuria compared with SP.WKY Gla 3a, SP.WKY Gla 2a/3a, and WKY strains, reaching signifi cance only in SHRSP. There were no differences in proteinuria between SHRSP and SP.WKY Gla 2a rats or among SP.WKY Gla 3a, SP.WKY Gla 2a/3a, and WKY rats.
Discussion
In this study, phenotypic analysis of the SP.WKY Gla 3a congenic strain has confi rmed the PP and SBP QTLs previously identifi ed by linkage analysis on RNO3. We have also shown that interactions between PP QTL on RNO2 and RNO3 are epistatic at baseline and during 1% salt challenge. Further phenotypic assessment of the single and bicongenic strains indicates that QTL on RNO3 are responsible for saltinduced renal pathology, whereas QTL on RNO2 seem to have greater impact on vascular function.
RNO3 has previously been shown to contain loci, which signifi cantly impact BP regulation particularly in the Dahl S rat, 21 -25 and also in other rat strains. 26 , 27 Although much of the genetic variation underlying hypertension is likely to be distinct between independently generated inbred rat strains, the overlap between the salt-induced renal pathology observed in the Dahl S model and the salt-loaded SHRSP described here suggests common implicated loci. Our data therefore confi rm the importance of this region, and also for the fi rst time, demonstrate an important role in the regulation of PP variability during salt loading. Monitoring of PP by radiotelemetry allows assessment of daytime and nighttime (diurnal) fl uctuations in PP. Our results identifi ed striking PP variability during salt challenge in the SHRSP, which was signifi cantly reduced in the RNO3 congenic and bicongenic strains. The inability of the SHRSP to tightly regulate diurnal PP variation may impact on end-organ damage, 28 , 29 because adverse cardiovascular consequences are shown to depend not only on absolute BP values, but also on BP variability. 30 In particular, the development, progression, and severity of renal damage have been associated with BP variation and instability. 29 , 31 It is suggested that long-term increase in PP results in higher-than-normal dissipation of pulsatile energy in the microcirculation of the kidney. Consequently, the relatively high level of pressure required within the glomerular arterioles to ensure high glomerular fi ltration rate may expose the glomerular capillaries to potentially damaging effects of increased PP, 29 leading to renal vascular damage.
The greater-than-additive interactions observed for PP in the bicongenic strain highlight the complex gene -environment relationships that exist in complex cardiovascular traits. Evidence for epistasis has previously been demonstrated for BP QTL located on different genetic regions of the same chromosome 8 , 32 and among loci located on different chromosomes. 4 , 6 , 7 , 9 -11 The identifi cation of such interactions can be used to infer genetic networks affecting complex traits and greatly assist in the detection of the underlying biological mechanisms. 33 , 34 The combined effects of introgressing RNO2 and RNO3 genetic intervals essentially normalizes SBP, DBP, and PP parameters in the bicongenic strain. This result, however, does not provide conclusive evidence that RNO2 and RNO3 QTL are entirely responsible for BP elevation in the SHRSP strain. Because of complex interactive relationships, the sum of the phenotypic effects of individual QTLs rarely explain the actual differences between the parental strains. 29 , 35 , 36 Moreover, because the introgressed congenic intervals encompass almost the whole of each respective chromosome, making the strains almost consomic, it is highly likely that the observed phenotypic effects are the result of several interacting loci. Dissection of these large regions will be an essential next step to identify and localize these potential interactions. One caveat to the interpretation of our results is that the lower RNO3 boundaries between the single RNO3 and the bicongenic strain differ by ≈ 1.9 Mbp. Although this difference has the potential to explain the observed phenotypic differences, our pairscan interaction analysis confi rms the location of the RNO3 QTL to ≈ 16.6 Mbp, which is distinct from the differential lower boundary segment (between 149.5 and 151.4 Mbp). Further dissection of the congenic interval will allow the potential impact of this region to be confi rmed or discounted.
Comparison of aortic vascular responses in SP.WKY Gla 2a and SP.WKY Gla 3a strains indicates that QTL on RNO2 have greater impact on vascular function than loci on RNO3. Our previous studies using RNO2 congenic and subcongenic strains, 13 -15 which encompass the implicated BP locus at D2Rat239 ( Figure 1 ) , showed reduced vascular oxidative stress 14 and infl ammation. 15 These fi ndings support the hypothesis that the RNO2 locus regulates BP through vascular functions, partly through vascular redox balance.
BP-independent QTL for CMI have previously been reported on RNO2 and RNO3. 37 -40 In the present study we observed signifi cant equivalent reductions in CMI and LVMI in SP.WKY Gla 2a and SP.WKY Gla 3a strains compared with the SHRSP. However, these changes in heart mass occurred in parallel with the observed BP reductions during baseline and salt-loading periods. Dissection of the congenic intervals will be necessary to establish whether the reduction in cardiac hypertrophy is secondary to the lowered BP or whether it is determined by distinct QTL regulating cardiac mass. RMI and salt-induced renal damage (identifi ed by histopathology scores and proteinuria) were signifi cantly reduced in the SP.WKY Gla 3a and SP.WKY Gla 2a/3a strains, but not in the SP.WKY Gla 2a strain. The signifi cant difference in renal pathology despite similar BP reduction suggests that the reduced renal pathological changes in RNO3 congenic strains are not simply because of hemodynamic changes. These results suggest that RNO3 QTL are more important for salt-induced renal damage than loci on RNO2. Dissection of the RNO3 congenic interval and identifi cation of the underlying causative genetic elements will be necessary to determine the mechanistic basis of the observed PP epistasis and salt-induced renal damage in the SHRSP.
Perspectives
RNO3 congenic and bicongenic strains have confi rmed the importance of the RNO3 congenic interval on PP variability and end-organ damage. These strains will allow interrogation of complex gene -gene and gene -environment interactions contributing to salt-sensitive hypertension and renal pathology in the SHRSP. Identifi cation of the underlying pathological mechanisms will allow discovery of new therapeutic targets for human essential hypertension and salt-induced renal damage. 
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